These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37422119)
1. Effects of 101BHG-D01, a novel M receptor antagonism, on allergic rhinitis in animal models and its mechanism. Shen H; Wei H; Jiang J; Yao H; Jia Y; Shen J; Li Y; Xie Q; Chen X; Xie Y; Dai H Eur J Pharmacol; 2023 Sep; 955():175902. PubMed ID: 37422119 [TBL] [Abstract][Full Text] [Related]
2. Gleditsia sinensis Lam. aqueous extract attenuates nasal inflammation in allergic rhinitis by inhibiting MUC5AC production through suppression of the STAT3/STAT6 pathway. Jung MA; Song HK; Jo K; Lee A; Hwang YH; Ji KY; Jung DH; Cai M; Lee JY; Pyun BJ; Kim T Biomed Pharmacother; 2023 May; 161():114482. PubMed ID: 36921533 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of Pulsatilla koreana Nakai extract on ovalbumin-induced allergic rhinitis by inhibition of Th2 cell activation and differentiation via the IL-4/STAT6/GATA3 pathway. Jung DH; Lee A; Hwang YH; Jung MA; Pyun BJ; Lee JY; Kim T; Song KH; Ji KY Biomed Pharmacother; 2023 Jun; 162():114730. PubMed ID: 37080090 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Tissue Distribution of Nasal Spray of a Novel Muscarinic Receptor Blocker, 101BHG-D01, in Dogs and Rats. Wei H; Wu L; Jia Y; Shen J; Li Y; Sun P; Xie Q; Chen X; Xie Y; Wang Y; Zhao Z Curr Drug Metab; 2022; 23(13):1080-1088. PubMed ID: 36464876 [TBL] [Abstract][Full Text] [Related]
5. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis. Piao CH; Song CH; Lee EJ; Chai OH Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322 [TBL] [Abstract][Full Text] [Related]
6. Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study. Chu NN; Huang K; Que LL; Ding Y; Gu XH; Zhang L; Wang JK; Chen XP; Sun ZG; He Q Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):509-521. PubMed ID: 35429285 [TBL] [Abstract][Full Text] [Related]
7. Silencing of forkhead box C1 reduces nasal epithelial barrier damage in mice with allergic rhinitis via epigenetically upregulating secreted frizzled-related protein 5. Shi Z; Zhao T; Li D; Wang C; Luo Y; Zheng Y Mol Immunol; 2024 Apr; 168():51-63. PubMed ID: 38422887 [TBL] [Abstract][Full Text] [Related]
8. Alpha-linolenic acid improves nasal mucosa epithelial barrier function in allergic rhinitis by arresting CD4 Ding Y; Wang Y; Zhang Y; Dang B; Hu S; Zhao C; Huang Y; Zheng G; Ma T; Zhang T Phytomedicine; 2023 Jul; 116():154825. PubMed ID: 37178572 [TBL] [Abstract][Full Text] [Related]
9. Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release. Bui TT; Piao CH; Song CH; Chai OH Int Immunopharmacol; 2017 Nov; 52():77-84. PubMed ID: 28886581 [TBL] [Abstract][Full Text] [Related]
10. miR-31 attenuates murine allergic rhinitis by suppressing interleukin-13-induced nasal epithelial inflammatory responses. Zhou F; Liu P; Lv H; Gao Z; Chang W; Xu Y Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179116 [TBL] [Abstract][Full Text] [Related]
11. Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis. Fan Y; Piao CH; Hyeon E; Jung SY; Eom JE; Shin HS; Song CH; Chai OH Int Immunopharmacol; 2019 May; 70():512-519. PubMed ID: 30884431 [TBL] [Abstract][Full Text] [Related]
12. Inotodiol suppresses allergic inflammation in allergic rhinitis mice. Chung J; Choi MR; Park SK; Kang JY; Chung EH; Park JT; Kim YM Int Forum Allergy Rhinol; 2023 Sep; 13(9):1603-1614. PubMed ID: 36579475 [TBL] [Abstract][Full Text] [Related]
13. Study on the Mechanism of Allergic Rhinitis Based on the Expression of FIB, PCT, hs-CRP, and Th17/Treg-IL10/IL-17 Axis Balance. Yu Mm Y; Yan Mm J Am J Rhinol Allergy; 2023 Jul; 37(4):429-437. PubMed ID: 36882999 [TBL] [Abstract][Full Text] [Related]
14. Apigenin attenuates inflammatory response in allergic rhinitis mice by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Li H; Zhang H; Zhao H Environ Toxicol; 2023 Feb; 38(2):253-265. PubMed ID: 36350155 [TBL] [Abstract][Full Text] [Related]
15. Higenamine alleviates allergic rhinitis by activating AKT1 and suppressing the EGFR/JAK2/c-JUN signaling. Wei X; Zhang B; Liang X; Liu C; Xia T; Xie Y; Deng X; Tan X Phytomedicine; 2021 Jun; 86():153565. PubMed ID: 33945919 [TBL] [Abstract][Full Text] [Related]
16. DMBT1 has a protective effect on allergic rhinitis. Zhao Y; Tao Q; Wu J; Liu H Biomed Pharmacother; 2020 Jan; 121():109675. PubMed ID: 31810134 [TBL] [Abstract][Full Text] [Related]
17. Effects of Ursolic Acid on the Expression of Th1-Th2-related Cytokines in a Rat Model of Allergic Rhinitis After PM2.5 Exposure. Sun N; Han Z; Wang H; Guo Z; Deng C; Dong W; Zhuang G; Zhang R Am J Rhinol Allergy; 2020 Sep; 34(5):587-596. PubMed ID: 32208746 [TBL] [Abstract][Full Text] [Related]
18. Bufotalin ameliorates ovalbumin-induced allergic rhinitis by restoring the Tregs. Ji Q; Ren S; Li L Microb Pathog; 2023 Jan; 174():105918. PubMed ID: 36455750 [TBL] [Abstract][Full Text] [Related]
19. Nonylphenol exacerbates ovalbumin-induced allergic rhinitis via the TSLP-TSLPR/IL-7R pathway and JAK1/2-STAT3 signaling in a mouse model. Wang Y; Cao Z; Zhao H; Gu Z Ecotoxicol Environ Saf; 2022 Sep; 243():114005. PubMed ID: 36029577 [TBL] [Abstract][Full Text] [Related]
20. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model. Zhang W; Ba G; Tang R; Li M; Lin H Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]